RLMD

$4.52+11.06%website ↗

RELMADA THERAPEUTICS, INC.

Market Cap

$453M

Sector

Materials

Industry

Pharmaceuticals

Beta

0.58

5yr monthly vs SPY

Price Chart

Loading…

Signals

Insider Velocity

Market & Alt Data

News

11

recent articles

Velocity Score

24.85x

Current Rate (90d)

4444.44/mo

Baseline Rate

0.00/mo

Unique Buyers (90d)

2

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-09-10	2026-09-11	Shenouda Maged	Chief Financial Officer	Purchase	79.8K	$4.25	$339K	1.00M	View
2026-09-10	2026-09-11	TRAVERSA SERGIO	Director & Chief Executive Officer	Purchase	100.0K	$4.10	$410K	1.50M	View
2026-09-09	2026-09-11	Shenouda Maged	Chief Financial Officer	Purchase	120.2K	$4.20	$505K	920.2K	View
2026-09-09	2026-09-11	TRAVERSA SERGIO	Director & Chief Executive Officer	Purchase	100.0K	$4.18	$418K	1.40M	View

Recent News

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga · 2026-09-11

Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference

Yahoo · 2026-09-01

After Plunging 18.5% in 4 Weeks, Here's Why the Trend Might Reverse for Relmada Therapeutics (RLMD)

Yahoo · 2026-08-31

Here's Why Relmada Therapeutics (RLMD) Is a Great 'Buy the Bottom' Stock Now

Yahoo · 2026-08-25

Informational purposes only, not investment advice.